Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
305
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+111K
-
Total reported value, excl. options
-
$6.1B
-
Value change
-
+$9.2M
-
Put/Call ratio
-
1.17
-
Number of buys
-
119
-
Number of sells
-
-137
-
Price
-
$51.58
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q3 2018
362 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q3 2018.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 305 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 159M outstanding shares and own 74.65% of the company stock.
Largest 10 shareholders include FMR LLC (20.5M shares), Vanguard Group Inc (11.1M shares), Clearbridge Investments, LLC (10.2M shares), WELLINGTON MANAGEMENT GROUP LLP (9.3M shares), BAILLIE GIFFORD & CO (8.96M shares), BB BIOTECH AG (8.67M shares), BlackRock Inc. (7.46M shares), WADDELL & REED FINANCIAL INC (3.83M shares), STATE STREET CORP (3.01M shares), and FIRST TRUST ADVISORS LP (2.13M shares).
This table shows the top 305 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.